期刊文献+

进展期胃癌HSP90的表达及其临床意义 被引量:5

Expression and significance of HSP90 in advanced gastric cancer
下载PDF
导出
摘要 目的探讨热休克蛋白90(HSP90)在进展期胃癌组织中的表达情况,并分析其与胃癌侵袭、转移及预后的关系。方法采用免疫组化染色法检测157例进展期胃癌组织中HSP90的表达情况,并分析HSP90表达与胃癌临床病理特征及预后的关系。结果胃癌组织中HSP90高表达率为68.2%(107/157)。HSP90表达与肿瘤大小、肿瘤部位、浸润深度、淋巴结转移及临床分期有关(P<0.05),与MMP-9表达呈正相关(r=0.514,P<0.001)。157例进展期胃癌患者的中位无复发生存时间(RFS)为27.0个月,中位总生存时间(OS)为33.0个月;HSP90低表达患者的中位RFS和OS均为60.5个月,而HSP90高表达者分别为15.0个月和20.0个月(P均<0.001)。Cox多因素分析显示,HSP90表达为影响胃癌预后的独立因素(P<0.05)。结论 HSP90表达与进展期胃癌的侵袭转移相关,其高表达提示预后不良。 Objective To investigate the expression of heat shock protein 90(HSP90) in advanced gastric cancer and evaluate its impact on tumor invasion and prognosis of advanced gastric cancer. Methods The expressions of HSP90 in 157 advanced gastric cancer patients were determined by immunohistochemistry. The relationships between HsPg0 and clinicopathologieal characteristics, prog- nosis of gastric cancer were analyzed. Results The high expression rate of HSP90 was 68.2% ( 107/157 ) in 157 advanced gastric cancer samples. The expression of HSP90 was closely related to tumor size, tumor site, depth of invasion, lymph node metastasis and clinical stage ( P 〈 O. 05 ). In addition, the expression of HSP90 was significantly correlated with MMP-9 iri gastric cancer tissues ( r = 0. 514, P 〈 0. 001 ). The postoperative median recurrence-free survival(RFS) and overall survival(OS) of 157 gastric' cancer patients were 27. 0 and 33.0 months, respectively. The postoperative median RFS and OS of patients with low expression of HSP90 were both 60. 5 months, while those of patients with high expression of HSP90 were 15.0 months and 20. 0 months ( P 〈 0. 001, P 〈 0. 001 ). Cox regression model showed that HSP90 expression was an independent factor predicting the prognosis of gastric cancer( P 〈 0. 05). Conclusion The expres- sion of HSP90 is correlated with tumor invasion and metastasis, and the high expression of HSP90 indicates a poor prognosis.
出处 《临床肿瘤学杂志》 CAS 2013年第5期394-397,共4页 Chinese Clinical Oncology
基金 广东省卫生厅资助项目(C2009030) 广州市科技局资助项目(2010GN-E00221)
关键词 热休克蛋白90 进展期胃癌 侵袭转移 预后 Heat shock protein 90 (HSP90) Advanced gastric cancer Invasion and metastasis Prognosis
  • 相关文献

参考文献1

共引文献433

同被引文献81

  • 1袁庆文,刘学政,刘学农,江平发.胃癌Hsp70-肽复合物致敏树突状细胞抗肿瘤作用的研究[J].江西医学院学报,2005,45(3):1-3. 被引量:7
  • 2Hong Ren,Ning Du,Gang Liu,Heng-Tong Hu,Wei Tian,Zhi-Ping Deng,Jing-Sen Shi.Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation[J].World Journal of Gastroenterology,2006,12(17):2789-2792. 被引量:25
  • 3Kostadima L, Pentheroudakis G, Pav|idis N. The missing kiss of life: transcriptional activity of the metastasis suppressor gene KISS1 in early breast cancer[J]. Antieancer Res, 2007, 27(14):2499-2504. 被引量:1
  • 4Mitchell DC, Abdelrahin M, Weng J, et al. Regulation of KISS- 1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-l[J]. J Biol Chem, 2006, 281(1):51-58. 被引量:1
  • 5Sakai K, Mori S, Kawamoto T, et al. Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas[J]. J Natl Cancer Inst, 1986, 77(5):1047-1052. 被引量:1
  • 6Grabsch H, Sivakumar S, Gray S, et al. HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value- conclusions from 924 cases of two independent series[J]. Cell Oncol, 2010, 32(1-2):57-65. 被引量:1
  • 7Bang Y J, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy venus chemotherapy alone for treatment of HER2-positive advanced gastric or gaatro-oesophageal junction cancer (TOGA): a phase 3, open-label, randomised controlled trial[J]. Lancet, 2010, 376(9742):687-697. 被引量:1
  • 8Zhang Z, Li Z, Gao C, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression[J]. Lab Invest, 2008, 88 (12):1358-1366. 被引量:1
  • 9Gao C, Zhang Z, Liu W, et al. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer[J]. Cancer, 2010, 116(1):41-49. 被引量:1
  • 10Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate muhidrug resistance by targeting BCL2 in human gastric cancer cells{J]. Int J Cancer, 2008, 123(2):372-379. 被引量:1

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部